Tower Research Capital LLC (Trc) Cerus Corp Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Cerus Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,781 shares of CERS stock, worth $10,810. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,781

Previous 17,159 66.31%

Holding current value

$10,810

Previous $30,000 66.67%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.7 - $2.39 $19,342 - $27,193	-11,378 Reduced 66.31%	5,781 $10,000
Q2 2024 Aug 13, 2024	BUY	$1.62 - $2.04 $25,199 - $31,732	15,555 Added 969.76%	17,159 $30,000
Q1 2024 May 15, 2024	SELL	$1.66 - $2.42 $99,653 - $145,277	-60,032 Reduced 97.4%	1,604 $3,000
Q4 2023 Feb 13, 2024	BUY	$1.25 - $2.35 $73,707 - $138,570	58,966 Added 2208.46%	61,636 $133,000
Q3 2023 Nov 14, 2023	SELL	$1.5 - $3.07 $3,586 - $7,340	-2,391 Reduced 47.24%	2,670 $4,000
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.9 $13,106 - $21,233	-7,322 Reduced 59.13%	5,061 $12,000
Q1 2023 May 09, 2023	BUY	$2.65 - $3.81 $29,142 - $41,898	10,997 Added 793.43%	12,383 $37,000
Q4 2022 Feb 10, 2023	SELL	$3.38 - $4.22 $214,643 - $267,986	-63,504 Reduced 97.86%	1,386 $5,000
Q3 2022 Nov 10, 2022	BUY	$3.43 - $5.83 $199,320 - $338,787	58,111 Added 857.22%	64,890 $234,000
Q2 2022 Aug 15, 2022	BUY	$4.41 - $5.69 $20,625 - $26,612	4,677 Added 222.5%	6,779 $36,000
Q1 2022 May 12, 2022	SELL	$4.81 - $6.99 $54,992 - $79,916	-11,433 Reduced 84.47%	2,102 $12,000
Q4 2021 Feb 14, 2022	SELL	$5.97 - $7.93 $185,852 - $246,868	-31,131 Reduced 69.7%	13,535 $92,000
Q3 2021 Nov 15, 2021	BUY	$4.79 - $6.68 $85,444 - $119,157	17,838 Added 66.49%	44,666 $272,000
Q2 2021 Aug 16, 2021	SELL	$5.35 - $6.35 $309,192 - $366,985	-57,793 Reduced 68.3%	26,828 $159,000
Q1 2021 May 17, 2021	BUY	$5.68 - $7.87 $385,876 - $534,656	67,936 Added 407.17%	84,621 $508,000
Q4 2020 Feb 16, 2021	SELL	$5.25 - $8.56 $649,755 - $1.06 Million	-123,763 Reduced 88.12%	16,685 $116,000
Q3 2020 Nov 16, 2020	BUY	$5.78 - $7.47 $584,681 - $755,635	101,156 Added 257.45%	140,448 $880,000
Q2 2020 Aug 13, 2020	BUY	$4.5 - $7.02 $176,814 - $275,829	39,292 New	39,292 $260,000
Q1 2020 May 15, 2020	SELL	$2.87 - $5.49 $861 - $1,647	-300 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$3.84 - $4.86 $1,152 - $1,458	300 New	300 $1,000
Q2 2019 Aug 13, 2019	SELL	$4.51 - $6.6 $2,570 - $3,762	-570 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$5.16 - $6.85 $361 - $479	70 Added 14.0%	570 $4,000
Q4 2018 Feb 14, 2019	BUY	$4.89 - $7.16 $2,445 - $3,580	500 New	500 $3,000
Q4 2017 Feb 09, 2018	SELL	$2.76 - $3.95 $18,756 - $26,844	-6,796 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.73 $15,087 - $18,553	6,796	6,796 $18,000

Others Institutions Holding CERS

# of Institutions

156

Shares Held

147M

Call Options Held

84.2K

Put Options Held

55.5K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $331M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Cerus Corp Transaction History